股號 / 名稱 | 總負債 | 淨值 |
ALRN Aileron Therapeutics Inc | 7,711,000.0 | 98,297,000.0 |
STRO Sutro Biopharma Inc | 305,378,000.0 | 98,024,000.0 |
INO Inovio Pharmaceuticals Inc | 34,672,200.0 | 94,441,960.0 |
RZLT Rezolute Inc | 10,422,000.0 | 91,728,000.0 |
AVTE Aerovate Therapeutics Inc | 15,917,000.0 | 90,904,000.0 |
AADI Aadi Bioscience Inc | 20,613,000.0 | 90,460,000.0 |
TKNO Alpha Teknova Inc | 38,551,000.0 | 90,036,000.0 |
RLYB Rallybio Corp | 10,202,000.0 | 89,157,000.0 |
AVRO AVROBIO Inc | 3,509,000.0 | 88,839,000.0 |
LQDA Liquidia Corp | 110,856,000.0 | 86,260,000.0 |
PSTX Poseida Therapeutics Inc | 177,986,000.0 | 84,594,000.0 |
LIFE aTyr Pharma Inc | 28,785,000.0 | 84,466,000.0 |
IMUX Immunic Inc | 20,579,000.0 | 83,576,000.0 |
BNGO Bionano Genomics Inc | 75,224,000.0 | 82,771,000.0 |
XOMA XOMA Corp | 137,079,000.0 | 82,341,000.0 |
CDXS Codexis Inc | 70,292,000.0 | 79,267,000.0 |
IMRX Immuneering Corp | 9,260,110.0 | 78,722,730.0 |
OVID Ovid Therapeutics Inc | 53,334,000.0 | 78,279,000.0 |
ELEV Elevation Oncology Inc | 33,143,000.0 | 75,818,000.0 |
ELDN Eledon Pharmaceuticals Inc | 5,999,000.0 | 74,819,000.0 |
TVTX Travere Therapeutics Inc | 589,476,000.0 | 74,071,000.0 |
TRVI Trevi Therapeutics Inc | 6,225,000.0 | 72,334,000.0 |
ENZ Enzo Biochem Inc | 28,302,000.0 | 70,775,000.0 |
ADAG Adagene Inc | 45,169,340.0 | 70,559,500.0 |
TLIS Talis Biomedical Corp | 25,558,000.0 | 69,116,000.0 |
GH Guardant Health Inc | 1,636,313,000.0 | 68,285,000.0 |
APLT Applied Therapeutics Inc | 83,940,000.0 | 67,294,000.0 |
SPRB Spruce Biosciences Inc | 20,915,000.0 | 66,624,000.0 |
RYTM Rhythm Pharmaceuticals Inc | 197,070,000.0 | 61,581,000.0 |
CRDF Cardiff Oncology Inc | 13,144,000.0 | 60,894,000.0 |
MNOV MediciNova Inc | 3,063,470.0 | 59,830,440.0 |
ALGS Aligos Therapeutics Inc | 68,106,000.0 | 59,796,000.0 |
SNSE Sensei Biotherapeutics Inc | 8,221,000.0 | 58,474,000.0 |
CRMD CorMedix Inc | 10,011,020.0 | 58,012,720.0 |
SABS SAB Biotherapeutics Inc | 26,641,810.0 | 57,299,440.0 |
SGMO Sangamo Therapeutics Inc | 72,264,000.0 | 56,697,000.0 |
PBYI Puma Biotechnology Inc | 177,086,000.0 | 53,442,000.0 |
LVTX LAVA Therapeutics NV | 50,532,000.0 | 51,178,000.0 |
BCAB Bioatla Inc | 39,481,000.0 | 49,716,000.0 |
ANAB AnaptysBio Inc | 358,057,000.0 | 47,778,000.0 |
LPTX Leap Therapeutics Inc | 10,591,000.0 | 47,372,000.0 |
DMAC DiaMedica Therapeutics Inc | 2,911,000.0 | 46,349,000.0 |
VSTM Verastem Inc | 77,318,000.0 | 46,221,000.0 |
ALIM Alimera Sciences Inc | 107,354,000.0 | 46,170,000.0 |
OCUP Ocuphire Pharma Inc | 5,787,000.0 | 46,057,000.0 |
OMGA Omega Therapeutics Inc | 142,326,000.0 | 41,354,000.0 |
MIST Milestone Pharmaceuticals Inc | 56,080,000.0 | 39,921,000.0 |
DTIL Precision BioSciences Inc | 147,535,000.0 | 37,206,000.0 |
LTRN Lantern Pharma Inc | 3,969,010.0 | 35,765,220.0 |
ABIO ARCA Biopharma Inc | 1,581,000.0 | 35,125,000.0 |
PPBT Purple Biotech Ltd | 10,095,000.0 | 34,207,000.0 |
CRVS Corvus Pharmaceuticals Inc | 6,720,000.0 | 33,364,000.0 |
WVE WAVE Life Sciences Ltd | 202,007,000.0 | 33,263,000.0 |
AYTU Aytu Biopharma Inc | 98,396,000.0 | 32,853,000.0 |
AKYA Akoya Biosciences Inc | 122,027,000.0 | 32,723,000.0 |
PRTG Portage Biotech Inc | 17,036,000.0 | 31,999,000.0 |
OCGN Ocugen Inc | 21,533,000.0 | 30,261,000.0 |
APRE Aprea Therapeutics Inc | 2,965,080.0 | 30,234,930.0 |
CUE Cue Biopharma Inc | 23,913,000.0 | 30,038,000.0 |
CARA Cara Therapeutics Inc | 60,296,000.0 | 29,803,000.0 |
INMB INmune Bio Inc | 17,810,000.0 | 29,023,000.0 |
CDXC Chromadex Corp | 25,128,000.0 | 28,951,000.0 |
CGTX Cognition Therapeutics Inc | 9,991,000.0 | 28,860,000.0 |
FBRX Forte Biosciences Inc | 3,332,000.0 | 28,685,000.0 |
CLGN Collplant Biotechnologies Ltd | 5,786,000.0 | 28,340,000.0 |
GLTO Galecto Inc | 4,318,000.0 | 28,159,000.0 |
MRSN Mersana Therapeutics Inc | 170,388,000.0 | 27,985,000.0 |
IMMX Immix Biopharma Inc | 6,432,450.0 | 27,915,150.0 |
GTHX G1 Therapeutics Inc | 74,287,000.0 | 27,739,000.0 |
PIRS Pieris Pharmaceuticals Inc | 11,922,000.0 | 26,758,000.0 |
GOSS Gossamer Bio Inc | 232,638,000.0 | 26,722,000.0 |
COCP Cocrystal Pharma Inc | 4,875,000.0 | 26,384,000.0 |
CLRB Cellectar Biosciences Inc | 16,742,290.0 | 26,166,150.0 |
HUMA Humacyte Inc | 135,314,000.0 | 26,152,000.0 |
PDSB PDS Biotechnology Corp | 33,259,130.0 | 26,130,950.0 |
MBRX Moleculin Biotech Inc | 12,144,000.0 | 26,073,000.0 |
XLO Xilio Therapeutics Inc | 56,844,000.0 | 25,765,000.0 |
SNPX Synaptogenix Inc | 5,529,470.0 | 25,584,200.0 |
ANIX Anixa Biosciences Inc | 767,000.0 | 24,605,000.0 |
SCPH scPharmaceuticals Inc | 53,888,000.0 | 24,566,000.0 |
ADAP Adaptimmune Therapeutics PLC | 233,635,000.0 | 24,375,000.0 |
UBX UNITY Biotechnology Inc | 34,875,000.0 | 23,988,000.0 |
KTTA Pasithea Therapeutics Corp | 2,718,410.0 | 23,398,450.0 |
LABP Landos Biopharma Inc | 6,742,000.0 | 23,154,000.0 |
FBIO Fortress Biotech Inc | 141,620,000.0 | 23,025,000.0 |
SBFM Sunshine Biopharma Inc | 6,139,600.0 | 21,207,360.0 |
EQ Equillium Inc | 22,503,000.0 | 21,094,000.0 |
XAIR Beyond Air Inc | 31,097,000.0 | 20,814,000.0 |
VTVT vTv Therapeutics Inc | 33,387,000.0 | 20,796,000.0 |
PULM Pulmatrix Inc | 11,373,000.0 | 19,018,000.0 |
MACK Merrimack Pharmaceuticals Inc | 441,000.0 | 18,747,000.0 |
INAB IN8BIO, Inc. | 8,023,000.0 | 17,526,000.0 |
LUMO Lumos Pharma Inc | 10,639,000.0 | 17,439,000.0 |
CMMB Chemomab Therapeutics Ltd | 5,154,000.0 | 16,997,000.0 |
FEMY Femasys Inc | 8,763,370.0 | 15,607,590.0 |
ETON Eton Pharmaceuticals Inc | 15,300,000.0 | 15,494,000.0 |
SYRS Syros Pharmaceuticals Inc | 119,671,000.0 | 15,057,000.0 |
TELA TELA Bio Inc | 57,453,000.0 | 14,384,000.0 |
NVCT Nuvectis Pharma Inc | 5,692,000.0 | 14,022,000.0 |
GRTS Gritstone bio Inc | 123,248,000.0 | 13,964,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例